Election 2014
SENSEX NIFTY
Ranbaxy Laboratories

News from other websites on Ranbaxy Laboratories

Ranbaxy's journey as a company to end after merger with Sun Pharma

Apr 20, 2014 at 12:00 | Source: NDTV Profit

New Delhi: Ranbaxy Laboratories will cease to exist as a company after completion of the $4 billion merger with Sun Pharmaceuticals, although its brands will be kept alive in over 100 markets. "The Ranbaxy entity will be merged into Sun Phar...

Glenmark pulls 2,900 bottles of ulcer drug in US

Apr 18, 2014 at 14:36 | Source: Business Today

Glenmark's NCE R&D Centre in Navi Mumbai. Glenmark Pharmaceuticals Ltd is recalling some 2,900 bottles of its stomach ulcer drug ranitidine in the United States after a foreign tablet was found in one of the bottles. Medicines produced in India, whi...

Weekly roundup: Market continues to be in poll vault mode; Sensex, Nifty up 1 per cent

Apr 12, 2014 at 16:42 | Source: Business Today

Both key indices Sensex and Nifty registered new highs and managed to gain for the third week in a row even as trading witnessed extreme volatility and profit-bookings during the truncated week.The BSE and NSE were closed on April 8 on account of "R...

Sun Pharma to make Rs 18cr open offer to Zenotech shareholders

Apr 12, 2014 at 10:00 | Source: NDTV Profit

Sun Pharma will make an open offer worth Rs 18.4 crore to acquire a little over 28 per cent stake in Zenotech Laboratories Ltd. The proposal comes in the wake of Sun Pharma's proposed $4-billion deal to merge Ranbaxy Laboratories with itself ...

Ranbaxy-Sun Pharma merger deal may close by year end: Daiichi

Apr 11, 2014 at 19:59 | Source: NDTV Profit

The $4 billion merger deal of Ranbaxy with Sun Pharma is expected to close by the end of 2014, Japanese drug maker Daiichi Sankyo, which holds majority stake in the former, said today. Daiichi had acquired a majority stake in Ranbaxy Laboratories in&...

Ranbaxy rallies over 3% intraday as FDA approves Gurgaon Romania R D centres

Apr 10, 2014 at 16:41 | Source: Economic Times

NEW DELHI: Ranbaxy Laboratories Ltd rallied as much as 3.1 per cent in intraday trade on Thursday after reports suggested that US drug regulator inspected its two centres in Gurgaon & Romania R&D and cleared it. Units of Ranbaxy's R&D centre at Gurga...

Late buy propels stocks

Apr 10, 2014 at 12:27 | Source: Calcutta Telegraph News

Mumbai, April 9: Frenetic buying at the fag end of trade today by foreign institutional investors, who anticipate market-friendly policies by the new government after the elections, took both the key stock indices to historic highs. While the Nifty ...

Sun bid to clear air on drug deal

Apr 10, 2014 at 12:27 | Source: Calcutta Telegraph News

Mumbai, April 9: Sun Pharma today denied insider trading allegations against its wholly owned arm Silverstreet Developers LLP in the $3.2-billion acquisition of Ranbaxy Laboratories. Silverstreet Developers, which had no holding in Ranbaxy till Sept...

Sensex set for new closing high; Top ten stocks in focus

Apr 10, 2014 at 10:46 | Source: Economic Times

NEW DELHI: After hitting fresh record highs, benchmark indices turned choppy in mid-morning trade on Thursday, weighed own by losses in FMCG, healthcare and metal stocks. The BSE Sensex rallied as much as 90 points to hit its fresh record high of 22...

Ranbaxy rallies over 3% as FDA approves Gurgaon Romania R D centres

Apr 10, 2014 at 10:01 | Source: Economic Times

NEW DELHI: Ranbaxy Laboratories Ltd rallied as much as 3.1 per cent in trade on Thursday after reports suggested that US drug regulator inspected its two centres in Gurgaon & Romania R&D and cleared it. At 09:40 a.m.; Ranbaxy was trading 2.1 per cen...

Sun Pharma denies insider trading charges in Ranbaxy deal

Apr 10, 2014 at 09:31 | Source: Economic Times

Sun Pharma on Wednesday strongly refuted the allegations of insider trading by Sudhir Valia, the executive director and brother-in-law of Dilip Shanghvi, in the run-up to the Ranbaxy deal. The 26% jump in Ranbaxy shares in the week before the deal a...

Sebi gets complaints on Ranbaxy share trade before merger deal

Apr 09, 2014 at 19:21 | Source: Economic Times

NEW DELHI: Market regulator Sebi has received multiple complaints about alleged irregularities in trading of Ranbaxy shares before the announcement of its multi-billion dollar merger deal with Sun Pharmaceutical. Securities and Exchange Board of Ind...

Crisil reaffirms 'A1 ' rating on Ranbaxy Laboratories bank facilities

Apr 09, 2014 at 19:21 | Source: Economic Times

HYDERABAD: Rating agency Crisil has reaffirmed its 'A1 ' rating on bank facilities of Ranbaxy Laboratories post Sun Pharmaceutical Industries's announcement to acquire 100 per cent stake in it. The deal is valued at an enterprise value of US $ 4 bill...

Brokers' group to ask SEBI to probe Ranbaxy trades

Apr 09, 2014 at 18:57 | Source: Business Today

The president of a brokerage association is planning to formally request that market regulator SEBI investigate trading in Ranbaxy Laboratories Ltd shares in the days leading up to its acquisition by Sun Pharmaceutical Industries. Ranbaxy shares sur...

Sun Pharma to buy Ranbaxy Laboratories in $3.2 bn all stock deal

Apr 09, 2014 at 18:57 | Source: Business Today

(Picture for representation only) Photo: Reuters Sun Pharmaceutical Industries will fully acquire troubled Ranbaxy Laboratories, in an all-stock transaction with a total equity value of $3.2 billion."Sun Pharmaceutical Industries Ltd and Ranbaxy Lab...

Sun Pharma to buy Ranbaxy in a $4 bn deal; smart move, says Dr Reddy's G V Prasad

Apr 09, 2014 at 18:57 | Source: Business Today

In what is being described by a landmark deal in Indian pharma, Sun Pharma and Ranbaxy on Monday morning announced that Sun Pharma is to acquire Ranbaxy in an all stock $ 4 billion deal. According to a release from Sun Pharma, it is to create world'...

Sun Pharma shares rise 7 per cent on Ranbaxy deal hopes

Apr 09, 2014 at 18:06 | Source: Economic Times

MUMBAI: Sun Pharma scrip soared nearly 7 per cent today following its move to fully acquire rival Ranbaxy in an all-stock transaction valued at $ 3.2 billion. The scrip ended 6.91 per cent up at Rs 627.80 on the BSE. During the day, it surged 8 per c...

Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in US: Sources

Apr 09, 2014 at 17:26 | Source: Economic Times

MUMBAI: Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States after completing a $3.2 billion takeover of its loss-making rival, sources with direct know...

Sebi likely to issue notice to Sun Pharma, Ranbaxy for insider trading: sources

Apr 09, 2014 at 16:56 | Source: Economic Times

MUMBAI: The Securities and Exchange Board of India (Sebi) is likely to issue notice to Sun Pharma and Ranbaxy over insider trading allegations following the merger pact between the two, say sources. The regulator has asked stock exchanges BSE and NS...

Good news trickles in for Ranbaxy, FDA approves Gurgaon Romania R D centres

Apr 09, 2014 at 14:56 | Source: Economic Times

NEW DELHI: In what might seem like irony, Ranbaxy Laboratories saw some good news from the US drug regulator just days before the announcement of its acquisition on Monday by Sun Pharmaceutical in a $4 billion deal inclusive of debt. Units of Ranbax...

Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Narendra Modi

88866.73 387.01 0.44%

1010

Bought today

675

Sold today

0.48%

User holding

video of the day

Chandra says satisfied with TCS' FY14, FY15 to be better

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.